Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

NovaBay Pharmaceuticals (NBY) Short-Term Debt repayments (2019 - 2022)

NovaBay Pharmaceuticals (NBY) has disclosed Short-Term Debt repayments for 5 consecutive years, with $105000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Short-Term Debt repayments changed N/A to $105000.0 in Q1 2022 year-over-year; TTM through Sep 2022 was $105000.0, a N/A change, with the full-year FY2019 number at $1.0 million, changed N/A from a year prior.
  • Short-Term Debt repayments was $105000.0 for Q1 2022 at NovaBay Pharmaceuticals, down from $1.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $1.0 million in Q1 2019 to a low of $105000.0 in Q1 2022.